West picks successor to retiring general counsel
Exton, Pennsylvania-based West Pharmaceutical Services has recruited Kimberly Banks MacKay as senior vice president, general counsel and corporate secretary, effective December 8, 2020.
MacKay will join West from The Segal Group, a privately held firm focused on employee benefits and investment consulting, where she has been senior vice president, general counsel and corporate secretary.
Before working at Segal, she spent more than 15 years at Novartis in roles such as head of US legal for Novartis Business Services, deputy compliance officer for Novartis Pharmaceuticals Corporation and lead counsel for a large Novartis business unit. Before her time at Novartis, she practiced securities law at MetLife, Lucent Technologies and law firm Milbank in New York.
MacKay will succeed George Miller, who has announced his intention to retire in February 2021. Miller will stay at West until the end of February as a special adviser to oversee the transition of duties.
West manufactures packaging components and delivery systems for injectable drugs and healthcare products.
‘After an extensive search, we are pleased that Kimberly is joining our West team,’ Eric Green, president and CEO, says in a statement. ‘She brings significant legal experience from her previous roles along with a deep understanding of the regulated environment in which we operate. As we continue to advance the importance of our mission as the leader in integrated containment and delivery of injectable medicines, Kimberly’s knowledge of this industry and her innovative and collaborative leadership style will be assets to our team.’